335 related articles for article (PubMed ID: 17327616)
21. Multimodality therapy for gastroesophageal cancers.
Wang KK
J Gastrointest Surg; 2002; 6(4):527-31. PubMed ID: 12127117
[No Abstract] [Full Text] [Related]
22. Management of Locally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction: Finally a Consensus.
Kleinberg L; Brock M; Gibson M
Curr Treat Options Oncol; 2015 Jul; 16(7):35. PubMed ID: 26112428
[TBL] [Abstract][Full Text] [Related]
23. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
[TBL] [Abstract][Full Text] [Related]
24. [Role of papillomavirus in adenocarcinoma of esophagogastric junction].
Zhang J; Tian XY; Wu XJ; Zong XL; Wu J; Ji JF
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(32):2259-62. PubMed ID: 21029672
[TBL] [Abstract][Full Text] [Related]
25. Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction.
Barbour AP; Rizk NP; Gerdes H; Bains MS; Rusch VW; Brennan MF; Coit DG
J Am Coll Surg; 2007 Oct; 205(4):593-601. PubMed ID: 17903735
[TBL] [Abstract][Full Text] [Related]
26. Management of gastroesophageal tumors.
Gee DW; Rattner DW
Oncologist; 2007 Feb; 12(2):175-85. PubMed ID: 17296813
[TBL] [Abstract][Full Text] [Related]
27. Case records of the Massachusetts General Hospital. Case 19-2009. A 63-year-old woman with carcinoma of the gastroesophageal junction.
Kwak EL; Hong TS; Berger DL; Forcione DG; Uppot RN; Lauwers GY
N Engl J Med; 2009 Jun; 360(25):2656-64. PubMed ID: 19535805
[No Abstract] [Full Text] [Related]
28. Is multimodality therapy an option to surgery alone in adenocarcinoma of the gastroesophageal junction?
Temple WJ
Can J Surg; 1990 Apr; 33(2):85-6. PubMed ID: 2268816
[No Abstract] [Full Text] [Related]
29. Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, part 1.
Schefter TE; Patel M; McCarter M; Kane M; Russ PD; Nash SR; Shah RJ; Mitchell JD
Oncology (Williston Park); 2005 May; 19(6):775-8, 783-4, 788 passim. PubMed ID: 15971452
[No Abstract] [Full Text] [Related]
30. [Perioperative therapy in esophageal and stomach carcinoma].
Stahl M; Wilke H; Meyer HJ
Med Klin (Munich); 1996 Apr; 91 Suppl 3():85-92. PubMed ID: 8692126
[No Abstract] [Full Text] [Related]
31. Clinical and Therapeutic Implications of the 8th Edition TNM Classification of Adenocarcinomas of the Esophagogastric Junction.
Birla R; Gandea C; Hoara P; Caragui A; Marica C; Vasiliu E; Constantinoiu S
Chirurgia (Bucur); 2018; 113(6):747-757. PubMed ID: 30596362
[TBL] [Abstract][Full Text] [Related]
32. Making It Stick: Management of Gastroesophageal Junction Adenocarcinoma with Poorly-Cohesive Cells (PCC).
Bouriez D; Gronnier C; Najah H; Collet D
Dig Dis Sci; 2022 Jun; 67(6):2005-2009. PubMed ID: 35430699
[No Abstract] [Full Text] [Related]
33. RE: Odze RD. unraveling the mystery of the gastroesophageal junction: a pathologist's perspective.
Chandrasoma P
Am J Gastroenterol; 2006 Jan; 101(1):199; author reply 199-200. PubMed ID: 16405557
[No Abstract] [Full Text] [Related]
34. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction.
Rice TW; Blackstone EH; Rusch VW
Ann Surg Oncol; 2010 Jul; 17(7):1721-4. PubMed ID: 20369299
[No Abstract] [Full Text] [Related]
35. Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, Part 2.
Schefter TE; Patel M; McCarter M; Kane M; Russ PD; Nash SR; Shah RJ; Mitchell JD
Oncology (Williston Park); 2005 Jun; 19(7):830, 835-6, 838 passim. PubMed ID: 16053033
[No Abstract] [Full Text] [Related]
36. [CLINICAL RECOMMENDATIONS FOR DIAGNOSIS, TREATMENT AND MONITORING OF PATIENTS WITH ESOPHAGEAL AND ESOPHAGOGASTRIC JUNCTION CANCERS].
Bišof V; Juretić A; Stančić-Rokotov D; Rustemović N; Miletić D; Boban M; Omrčen T; Razumović JJ; Pavlović I; Fröbe A; Čonkaš M; Rakušić Z; Gugić D
Lijec Vjesn; 2016; 138(9-10):233-9. PubMed ID: 30148543
[TBL] [Abstract][Full Text] [Related]
37. Management of Locally Advanced Gastroesophageal Cancer: Still a Multidisciplinary Global Challenge?
Al-Batran SE; Lorenzen S
Hematol Oncol Clin North Am; 2017 Jun; 31(3):441-452. PubMed ID: 28501086
[TBL] [Abstract][Full Text] [Related]
38. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
39. Curative management of adenocarcinoma of the oesophagus and oesogastric junction--current recommendations of the Belgian Working Group.
Van Laethem JL; Baert F; Buset M; de Hemptine B; De Ronde T; Honoré P; Lerut T; Scaillet P; Van Cutsem E;
Acta Gastroenterol Belg; 2000; 63(3):304-6. PubMed ID: 11189997
[No Abstract] [Full Text] [Related]
40. Effect of operation-introducing hyperthermic intraperitoneal chemotherapy on cellular immune function in patients with adenocarcinoma of the esophagogastric junction.
Nie Z; Huang Y; Li S; Li L
Asian J Surg; 2022 Jan; 45(1):559-560. PubMed ID: 34656412
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
